Jessica Hochberg

965 total citations
43 papers, 552 citations indexed

About

Jessica Hochberg is a scholar working on Pathology and Forensic Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jessica Hochberg has authored 43 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 13 papers in Oncology and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jessica Hochberg's work include Lymphoma Diagnosis and Treatment (18 papers), Acute Lymphoblastic Leukemia research (12 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Jessica Hochberg is often cited by papers focused on Lymphoma Diagnosis and Treatment (18 papers), Acute Lymphoblastic Leukemia research (12 papers) and Hematopoietic Stem Cell Transplantation (11 papers). Jessica Hochberg collaborates with scholars based in United States, France and Switzerland. Jessica Hochberg's co-authors include Mitchell S. Cairo, Janet Ayello, Carmella van de Ven, Yaya Chu, Matthew J. Barth, Myron S. Czuczman, Erin Morris, Ian M. Waxman, Kara M. Kelly and Nader Kim El‐Mallawany and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Jessica Hochberg

40 papers receiving 547 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jessica Hochberg United States 14 279 191 178 125 118 43 552
Masaaki Kumagai Japan 12 164 0.6× 111 0.6× 125 0.7× 301 2.4× 156 1.3× 28 633
Pablo Parker United States 9 286 1.0× 148 0.8× 132 0.7× 174 1.4× 79 0.7× 10 741
Nathalie Aladjidi France 14 167 0.6× 171 0.9× 186 1.0× 69 0.6× 51 0.4× 53 615
Daniel Couriel United States 10 195 0.7× 299 1.6× 131 0.7× 61 0.5× 96 0.8× 20 663
Bhausaheb Bagal India 10 146 0.5× 92 0.5× 101 0.6× 93 0.7× 46 0.4× 104 413
Andreas K. Klein United States 15 350 1.3× 177 0.9× 200 1.1× 40 0.3× 46 0.4× 54 731
Sumithira Vasu United States 13 380 1.4× 231 1.2× 93 0.5× 89 0.7× 51 0.4× 78 851
Celina Ledesma United States 12 248 0.9× 87 0.5× 200 1.1× 156 1.2× 43 0.4× 39 538
Ni‐Chun Tsai United States 16 382 1.4× 130 0.7× 321 1.8× 97 0.8× 39 0.3× 48 712
Man Updesh Singh Sachdeva India 13 101 0.4× 126 0.7× 94 0.5× 141 1.1× 87 0.7× 118 648

Countries citing papers authored by Jessica Hochberg

Since Specialization
Citations

This map shows the geographic impact of Jessica Hochberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Hochberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Hochberg more than expected).

Fields of papers citing papers by Jessica Hochberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica Hochberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Hochberg. The network helps show where Jessica Hochberg may publish in the future.

Co-authorship network of co-authors of Jessica Hochberg

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica Hochberg. A scholar is included among the top collaborators of Jessica Hochberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica Hochberg. Jessica Hochberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hochberg, Jessica, Qiuhu Shi, Yaya Chu, et al.. (2024). Defibrotide Reduces Hypercoagulable State in Patients with Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812). Blood. 144(Supplement 1). 2515–2515. 1 indexed citations
3.
Ehrhardt, Matthew J., Stephanie B. Dixon, Jennifer A. Belsky, & Jessica Hochberg. (2023). Late effects and frontline treatment selection for children with non-Hodgkin lymphoma. Best Practice & Research Clinical Haematology. 36(1). 101443–101443. 5 indexed citations
4.
Hochberg, Jessica, Qiuhu Shi, Allyson Flower, et al.. (2022). Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin’s lymphoma: a phase II, non-randomized controlled trial. Journal for ImmunoTherapy of Cancer. 10(5). e004445–e004445. 8 indexed citations
7.
Flower, Allyson, Lauren Harrison, Michael A. Pulsipher, et al.. (2019). Hematopoietic Stem Cell Transplantation with Human Placenta-Derived Stem Cells Combined with Unrelated Cord Blood for Malignant and Non-Malignant Disorders (IND 14949). Biology of Blood and Marrow Transplantation. 25(3). S214–S215. 1 indexed citations
8.
Audino, Anthony, Matthew J. Barth, Janet Ayello, et al.. (2019). Polatuzumab Vedotin, an Antibody-Drug Conjugate Targeting CD79b, Is a Highly Active Agent Against Burkitt Lymphoma and Primary Mediastinal B-Cell Lymphoma. Blood. 134(Supplement_1). 3963–3963. 3 indexed citations
9.
Hochberg, Jessica, Allyson Flower, Laurence Brugières, & Mitchell S. Cairo. (2018). NHL in adolescents and young adults: A unique population. Pediatric Blood & Cancer. 65(8). e27073–e27073. 15 indexed citations
10.
Yin, Changhong, Jessica Hochberg, Janet Ayello, et al.. (2018). Ruxolitinib significantly enhances in vitro apoptosis in Hodgkin lymphoma and primary mediastinal B-cell lymphoma and survival in a lymphoma xenograft murine model. Oncotarget. 9(11). 9776–9788. 18 indexed citations
11.
Schulte, Rachael, Allyson Flower, Jessica Hochberg, et al.. (2018). Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature. Leukemia & lymphoma. 59(10). 2360–2368. 18 indexed citations
12.
Ayello, Janet, Jessica Hochberg, Allyson Flower, et al.. (2016). Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy. Experimental Hematology. 46. 38–47. 17 indexed citations
14.
Chu, Yaya, Jessica Hochberg, Janet Ayello, et al.. (2014). Targeting CD20+ Aggressive B-cell Non–Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice. Cancer Immunology Research. 3(4). 333–344. 143 indexed citations
15.
Galardy, Paul J., Jessica Hochberg, Sherrie L. Perkins, et al.. (2013). Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature BNHL: a Children's Oncology Group Report. British Journal of Haematology. 163(3). 365–372. 39 indexed citations
16.
Chu, Yaya, Janet Ayello, Jessica Hochberg, et al.. (2012). Abstract 3511: Genetically engineered natural killer (NK) cell immunotherapy for poor risk B-cell (CD20+) leukemia and lymphoma (L/L). Cancer Research. 72(8_Supplement). 3511–3511. 1 indexed citations
18.
Hochberg, Jessica & Mitchell S. Cairo. (2009). Childhood and adolescent lymphoblastic lymphoma: End of the beginning and future directions. Pediatric Blood & Cancer. 53(6). 917–919. 1 indexed citations
19.
Hochberg, Jessica, Ian M. Waxman, Kara M. Kelly, Erin Morris, & Mitchell S. Cairo. (2008). Adolescent non‐Hodgkin lymphoma and Hodgkin lymphoma: state of the science. British Journal of Haematology. 144(1). 24–40. 68 indexed citations
20.
Hochberg, Jessica & Mitchell S. Cairo. (2008). Rasburicase: future directions in tumor lysis management. Expert Opinion on Biological Therapy. 8(10). 1595–1604. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026